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Insulin receptor and epidermal growth factor receptor
dephosphorylation by three major rat liver protein-tyrosine
phosphatases expressed in a recombinant bacterial system
Naotake HASHIMOTO, Wei-Ren ZHANG and Barry J. GOLDSTEIN*
Research Division, Joslin Diabetes Center and Department of Medicine,
Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02215, U.S.A.
Protein-tyrosine phosphatases (PTPases) play an essential role in the regulation of signal transduction mediated by
reversible protein-tyrosine phosphorylation. In order to characterize individual rat hepatic PTPases that might have
specificity for autophosphorylated receptor tyrosine kinases, we isolated cDNA segments encoding three PTPases (PTPase
1B, LAR and LRP) that are expressed in insulin-sensitive liver and skeletal muscle tissue, and evaluated their catalytic
activity in vitro. The intrinsic PTPase activities of the full-length PTPase lB protein and the cytoplasmic domains of LAR
and LRP were studied by expression of recombinant cDNA constructs in the inducible bacterial vector pKK233-2 using
extracts of a host strain of Escherichia coli that lacks endogenous PTPase activity. Each of the cloned cDNAs
dephosphorylated a cognate phosphopeptide derived from the regulatory region of the insulin receptor. Despite having
only 30-39 % sequence identity in their catalytic domains, LAR and PTPase lB had similar relative activities between the
peptide substrate and intact insulin receptors, and also displayed similar initial rates of simultaneous dephosphorylation
of insulin and epidermal growth factor (EGF) receptors. In contrast, LRP exhibited a higher rate of dephosphorylation
of both intact receptors relative to the peptide substrate, and also dephosphorylated EGF receptors more rapidly than
insulin receptors. These studies indicate that three PTPases with markedly divergent structures have the catalytic potential
to dephosphorylate both insulin and EGF receptors in intact cells and that redundant PTPase activity may occur in vivo.
For these PTPases to have specific physiological actions in intact cells, they must be influenced by steric effects of the
additional protein segments of the native transmembrane enzymes, cellular compartmentalization and/or interactions
with regulatory proteins.
INTRODUCTION
The reversible phosphorylation of protein-tyrosine residues
plays an essential role in the control of a variety of specialized
cellular functions, including signal transduction by cell surface
receptors with tyrosine kinase activity, such as those for insulin
and epidermal growth factor (EGF) (Yarden & Ullrich, 1988).
The tyrosine phosphorylation state of cellular proteins in these
pathways is regulated by a balance between the action of tyrosine
kinases, which may be the autophosphorylated receptors them-
selves, and specific enzymes that contain protein-tyrosine
phosphatase (PTPase) activity (Hunter, 1989).
While much has been learned about the cellular and molecular
physiology of tyrosine kinases over the past decade, only recently
have a number of full-length and partial PTPase sequences been
determined by several laboratories, revealing that they comprise
a family of related proteins (reviewed by Fischer et al., 1991).
The catalytic domain of these PTPases consists of single or
tandemly duplicated segments of approx. 260 amino acids that
contain a series of residues that are highly conserved. Two
distinct classes of PTPase have also been distinguished by their
overall structure. One class includes the single-domain PTPase
lB and a related enzyme isolated from a T-cell cDNA library,
both of which lack transmembrane domains (Cool et al., 1989;
Guan et al., 1990; Chernoff et al., 1990). The other class of
PTPases consists of those with a receptor-like transmembrane
structure and includes the tandem-domain enzymes leucocyte
common antigen (LCA; CD45), whose expression is limited to
haematopoietic cells (Tonks et al., 1988a; Thomas, 1989), and
two structurally similar PTPases, LAR (for LCA-related) and
LRP (for LCA-related phosphatase; also called PTP-a) which
have wider tissue distributions (Streuli et al., 1988; Matthews et
al., 1990; Sap et al., 1990; Krueger et al., 1990; Jirik et al., 1990;
Kaplan et al., 1990). Although the cloning ofPTPase homologues
has progressed rapidly, little is known about their potential
physiological roles, especially in non-haematopoietic tissues.
Only recently have data been reported on the biochemical
characteristics of individual PTPases and, importantly, the
substrates of these enzymes in intact cells are not known.
One of the fundamental physiological roles of PTPases is their
action on hormone and growth factor receptors with tyrosine
kinase activity and their potential modulation of signal
transduction through these pathways (Cicirelli et al., 1990;
Tonks et al., 1990). We are particularly interested in the
regulation of insulin signalling by reversible tyrosine
phosphorylation under physiological conditions in tissues
involved in normal metabolic homeostasis (Goldstein, 1992).
Since the main target tissues of insulin action in the control of
glucose metabolism are skeletal muscle and liver, we have begun
to identify specific PTPases that are expressed in these tissues in
order to evaluate their physiological role in the regulation of
insulin receptor signalling, and ultimately their possible in-
volvement in states of insulin resistance (Goldstein et al., 1991,
1992; McGuire et al., 1991).
Recently we reported that LAR and LRP are major PTPase
homologues expressed in rat liver and muscle (Zhang &
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Goldstein, 1991). These results are extended in the present study,
where we show that PTPase lB is also abundantly expressed in
normal liver and skeletal muscle tissue. We further investigated
the catalytic activity of these three major PTPase enzymes, as
expressed in a recombinant bacterial system, to assess their
relative activity against intact, autophosphorylated insulin and
EGF receptors, which represent potential physiological
substrates for these enzymes in intact cells.
MATERIALS AND METHODS
Materials
A mixed oligo(dT) and random hexamer-primed cDNA library
in AZAPII prepared from a male Sprague-Dawley rat liver,
Escherichia coli XL-l blue host cells and the helper phage R408
were obtained from Stratagene (La Jolla, CA, U.S.A.). DNA
restriction endonucleases, modifying enzymes and size markers
were purchased from New England Biolabs (Beverly, MA,
U.S.A.). Oligonucleotides were obtained from Oligos Etc.
(Guilford, CT, U.S.A.), and the Joslin DERC Molecular Core
facility. Thermus aquaticus DNA polymerase was obtained from
Perkin-Elmer Cetus (Norwalk, CT, U.S.A.). Modified T7 DNA
polymerase (Sequenase) was obtained from U.S. Biochemical
(Cleveland, OH, U.S.A.). [a-35S]dATP and [y-32P]ATP were
from New England Nuclear (Beverly, MA, U.S.A.). The
pKK233-2 expression vector was obtained from Pharmacia
(Piscataway, NJ, U.S.A.). Wheat-germ-agglutinin-agarose was
from Vector Laboratories (Burlingame, CA, U.S.A.). Aprotinin,
lysozyme and N-acetyl-D-glucosamine were purchased from
Sigma Chemical Co. (St. Louis, MO, U.S.A.). EGF was from
Collaborative Research (Bedford, MA, U.S.A.). Dowex AG
I-X2 acetate and Bio-Gel P-6 were from Bio-Rad Laboratories
(Richmond, CA, U.S.A.). The insulin receptor peptide substrate
(residues 1154-1165; numbered according to Ebina et al., 1985)
was synthesized by Dr. Steven Shoelson (Joslin Diabetes Center,
Boston, MA, U.S.A.).
Animals
Male Sprague-Dawley rats weighing 150-175 g were obtained
from Taconic Farms (Germantown, NY, U.S.A.), and had free
access to food and water.
Preparation of tissue RNA
Total RNA was prepared from the indicated tissues by
homogenization in guanidinium thiocyanate, extraction with
phenol/chloroform and precipitation from propan-2-ol
(Chomczynski & Sacchi, 1987). In some experiments the
polyadenylated mRNA fraction was enriched by chromato-
graphy over oligo-(dT}-cellulose (Aviv & Leder, 1972).
cDNA cloning
To obtain a cDNA insert encoding the rat homologue of the
LAR PTPase, 1 x 106 phage plaques of the rat liver cDNA
library were hybridized in a solution containing 40% (v/v)
formamide, 0.1 % (w/v) Ficoll, 0.1 % (w/v) polyvinylpyrrolidone,
0.1% (w/v) BSA, S mM-EDTA, 0.1% (w/v) SDS, 100 ,g of
denatured salmon sperm DNA/ml, 750 mM-NaCl and 50 mm-
NaH2PO4, pH 7.4, at 35 °C with a labelled cDNA encoding all
but the extreme 5' end of the human LAR sequence (kindly
provided by Dr. Haruo Saito, Dana Farber Cancer Institute,
Boston, MA, U.S.A.). Filters were washed at 50 °C in buffer
containing 75 mM-NaCl and 0.1 % (w/v) SDS in 7.5 mM-sodium
citrate, pH 7.0. Insert-bearing pBluescript phagemids were
excised from the AZAPII clones using the helper phage R408 and
plasmids were prepared by infection of XL-1 Blue E. coli host
cells. Double-stranded sequencing was performed using
Sequenase, as described by the manufacturer, using T3 and T7
promoter sequencing primers, or synthetic 17-mer oligo-
nucleotides derived from known sequences (Sanger et al., 1977).
For large (> 2 kb) inserts, nested deletions were prepared for
sequencing each strand, as described previously (Goldstein &
Dudley, 1990).
cDNA inserts encoding the rat PTPase lB and LRP enzymes
were obtained by a coupled reverse transcription/PCR technique.
For PTPase 1 B, a specific antisense oligonucleotide primer
derived from amino acid residues at the 3' end of the rat PTPase
IB coding region (Guan et al., 1990) was used in a reverse
transcription reaction on rat liver total RNA as described
previously (Goldstein & Dudley, 1990). This was followed by
cDNA amplification with the addition of an oligonucleotide
primer that flanks the extreme 5' end of the 1.3 kb cDNA coding
region. The amplification primers also incorporated NcoI and
HindIII restriction sites for subcloning of the cDNA products in
frame into the bacterial expression vector pKK233-2 (Sambrook
et al., 1989). For the LRP PTPase, primers derived from the
published murine LRP cDNA sequence (Matthews et al., 1990)
were used for reverse transcription of rat liver RNA and
subsequent cDNA amplification. The antisense primer extended
from just beyond the translation stop codon and covered the 5
amino acid residues that lie at the immediate 3' end of the coding
region. In order to express the intact cytoplasmic domain of
LRP, the 5' end amplification primer was identical to the cDNA
encoding the 6 amino acid residues that immediately follow the
transmembrane domain, with the addition of an NcoI site for
translation initiation and subcloning into pKK233-2. The sub-
cloned cDNA inserts for PTPase lB and LRP were then
sequenced as described above.
Sequence analysis
PTPase sequence identities and alignments were identified
using programs from the Molecular Engineering Research Center
at Boston University (Boston, MA, U.S.A.).
Northern blot analysis
Tissue poly(A)+ RNA (20,ug) was fractionated by electro-
phoresis in 1 % agarose gels containing 0.66 M-formaldehyde
and transferred to a nitrocellulose filter (Davis et al., 1986).
The filter was hybridized and washed under high-stringency
conditions with a cDNA probe labelled by random hexamer
priming (Feinberg & Vogelstein, 1983).
cDNA expression in a bacterial system
As described above, the cDNA inserts for PTPase lB and
rat LRP obtained by cDNA amplification were directly sub-
cloned into the isopropylthio-/-D-galactoside (IPTG)-inducible
expression vector pKK233-2 (Amann & Brosius, 1985). For
LAR, one cDNA insert isolated from the rat liver library that
spanned the entire cytoplasmic domain of LAR was used as a
template in a modified PCR to subclone this region in frame into
the pKK233-2 vector. For this reaction, a 5' end oligonucleotide
primer (AAAGAGGAAGAGAACACA) was designed for
DNA amplification of the intracellular segment of rat LAR that
would allow this insert to be expressed in frame after the addition
of PstI linkers and ligation to the PstI site of pKK233-2. In order
to minimize the possibility of error incorporation during cDNA
amplification, the 5' end primer and a Te promoter primer were
used with 3 jtg of the plasmid cDNA template, and reaction
conditions were limited to 10 cycles that consisted of 55 °C for
90 s, 72 IC for 150 s and 96 °C for 60 s (Goldstein & Dudley,
1990). The amplification products were gel-purified and treated
with PstI methylase to block the internal PstI sites, and
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phosphorylated PstI linkers (New England Biolabs) were added
(Sambrook et al., 1989). After digestion with PstI, the insert was
symmetrically subcloned into the unique PstI site of pKK233-2.
This construct was completely sequenced and found to contain
no amplification errors.
For protein expression, the plasmid was transformed into
E. coli strain DHB4 [AphoA phoR (F' lacIQ pro)] which carries
a defect in the genes encoding alkaline phosphatase activity
(Boyd et al., 1987). Cultures were induced with 2 mM-IPTG and
the bacteria were sedimented, lysed with lysozyme and subjected
to three cycles of freeze-thawing in a solid C02/ethanol bath.
Supernatants were prepared by treating the lysed cells with
DNAase I and removing insoluble material by centrifugation at
15000 g for 15 min at 4 'C (Streuli et al., 1989).
Assay of recombinant PTPase activities in bacterial extracts
A synthetic peptide derived from the autophosphorylated
regulatory region of the insulin receptor f-subunit (residues
1154-1165) was used as a phosphatase substrate. The peptide
was labelled with insulin receptors that were solubilized from a
membrane fraction of Chinese hamster ovary cells transfected
with the cloned human insulin receptor (White et al., 1987)
and partially purified by wheat-germ-agglutinin-agarose
chromatography (Kasuga et al., 1985). Aliquots of the lectin
column eluate were incubated with 1 /LM-insulin for 30 min at
4 °C, after which 500 uCi of [y-32P]ATP was added at a final
concentration of 25 uM, followed by MnCl2 to 5 mm and 1 mg of
the 1154-1165 peptide in a volume of 350 ,ul. After 16 h at 4 °C,
I ml of 5 % (w/v) trichloroacetic acid was added and the 32p_
labelled peptide in the supernatant was purified on AGI-X2
acetate resin followed by passage through a C18 Sep-Pak cartridge
(Waters Associates, Milford, MA, U.S.A.) and lyophilized
(Sparks & Brautigan, 1985). When prepared in this way, the
peptide is monophosphorylated on the tyrosine-1 162 residue (S.
Shoelson, unpublished work).
PTPase activity was assayed by incubating portions of the
bacterial extract with labelled substrate in a reaction buffer
containing 1 mM-dithiothreitol (DTT) and 2 mM-EDTA in
50 mM-Hepes, pH 7.0, at 30 'C. Reactions were terminated by
the addition of 1 mM-H2SO4 and 5 mM-silicotungstic acid, and
[32P]P released from the labelled peptide was measured by
organic extraction of the supernatant (Shacter, 1984). Specific
activity is presented as pmol of P04 released/min per mg of
protein.
were subjected to electrophoresis in gels containing SDS and
7.5 % polyacrylamide (Laemmli, 1970). The incorporation of 32P
into the 95 kDa insulin receptor f-subunit and the 170 kDa EGF
receptor polypeptide was quantified by scanning densitometry of
gel autoradiograms (Molecular Dynamics).
Statistical analysis
GraphPAD software (San Diego, CA, U.S.A.) was used to
calculate t test and analysis of variance results. Bonferroni's
correction was employed for calculation of P values in the event
of multiple comparisons.
RESULTS
cDNA cloning of PTPase homologues in rat liver and skeletal
muscle
A total of 106 plaques of the rat liver cDNA library were
screened with probes from human LAR cDNA. After secondary
screenings and sequence analysis, seven overlapping cDNA
inserts were identified that had 98 % overall sequence identity
with human LAR in the deduced 623 amino acids of its
cytoplasmic domain and thus encoded the rat homologue of
LAR (Pot et al., 1991; Goldstein et al., 1992).
A cDNA segment encoding the cytoplasmic domain of the rat
homologue of the PTPase designated LRP was obtained by
cDNA amplification. After subcloning and sequence analysis,
the deduced 629-amino-acid sequence of this clone had over
97 % identity with the corresponding region of the alternatively
spliced murine LRP cDNA that lacked the 108-nucleotide exon
insertion in the PTPase domain (Matthews et al., 1990; Sap et
al., 1990). The cDNA sequence of the entire 432-amino-acid
protein-coding region for the rat homologue of PTPase 1 B, also
obtained by cDNA amplification, was identical to that described
by Guan et al. (1990).
In previous work we demonstrated by amplification ofcDNA,
library screening and Northern blot hybridization that LAR and
LRP are major PTPases expressed in normal rat liver and
B K M S
Dephosphorylation of insulin and EGF receptors
Growth factor receptors were obtained from a solubilized
membrane fraction of rat liver by wheat-germ-agglutinin-agarose
chromatography (Kasuga et al., 1985). Insulin and EGF receptors
(4 ,tg of protein from the lectin column eluate) were labelled in a
0.6 ml reaction containing 1 ,uM-insulin, 5 ,tg of EGF/ml, 5 mm-
MnCl2, 25 ,uM-ATP and 375 ,#Ci of [y-32P]ATP (3000 Ci/mmol)
in 50 mM-Hepes, pH 7.6, at 4 °C for 60 min. Unincorporated
ATP was removed using a Bio-Gel P6 spin column, and 30 ,ul
aliquots of the labelled receptors were incubated with 31.5 ,ug of
bacterial lysate protein in a 150,l reaction containing 1 mm-
DTT and 2 mM-EDTA in 50 mM-Hepes, pH 7.0, at 30 'C. After
incubation for the indicated period of time, 0.5 ml of a chilled
stop solution containing 10 mM-ATP, 10 mM-sodium pyro-
phosphate, 4 mM-EDTA, 100 mM-NaF, 5 mM-sodium vanadate,
0.1 mg of aprotinin/ml and 2 mM-phenylmethanesulphonyl
fluoride (PMSF) in 50 mM-Hepes buffer, pH 7.6, was added.
Samples were immunoprecipitated with anti-phosphotyrosine
antibody, absorbed to Trisacryl-Protein A and washed. After
boiling in gel sample buffer containing 100 mM-DTT, samples
Vol. 284
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Fig 1. Northern blot analysis of PTPase 1B mRNA expression in several
rat tissues
Tissues were brain (B), kidney (K), liver (L), muscle (M) and spleen
(S). A 20 ,g portion of poly(A)+ RNA from each of the indicated
tissues was denatured and subjected to electrophoresis in 1%
agarose/0.66 M-formaldehyde gels. The RNA was then transferred
to a nitrocellulose filter and hybridized under high-stringency
conditions with a 32P-labelled cDNA probe encoding the entire
coding region of PTPase lB as described in the Materials and
methods section. A representative autoradiogram is shown.
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(a)
PTPaselB: AKLPKNKNRNRYRDVSPFDHSRIKL.... HQED.... NDYINASLIKMEEAQRSYILTQG
rLAR Dl: SNSEV--PK---AN-IAY----VL-....TSI-gvpgS-----NY-DGYRK-NA--A---
rLRP Dl: -SKEE--EK---VNIL-Y----VH-tpveGVP-....S------F-NGYQEKNKF-AA--
PTPaselB: PLPNTCGHFWEMVWEQKSRGVVMLNRIMEKGSLKCAQYWPQKEEKEMVFDDTNLKLTLIS
rLAR Dl: ---E-M-D--R-----RIAT---MT-LE--SRV--D----ARGTETYGL....IQV--VD
rLRP Dl: -KEE-VND--R-I---NTATI--VTNLK-RKEC-------DQGCWTYGNVRVSVEDVTVL
PTPaselB: EDVKSYYTVRQLELENLATQEAREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSP
rLAR Dl: TVELAT--M-TFA-HKSGSS-K--LRQ-QFMA---H----Y-TPI-A--RR-KACNP-..
rLRP Dl: V-YTVRKFCI-QVGDVTNRKPQ-L-TQ--F-S-------FT-IGM-K--K--KACN..PQ
PTPaselB: EHGPIVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRRFRMGLIQTADQ
rLAR DI: DA--M-------V--T-C-IVI-...AMLERM-HEKT---YGHVTC--SQ-NYMV--E--
rLRP Dl: YA-A--------V--T---VVI-...AML-MMHSERK--VYGFVSRI-AQ-CQMV--DM-
PTPaselB: LRFSYLAVIEGAKFIMG
rLAR Dl: YV-IHE-LL-A-MCGHT
rLRP D1: YV-I-Q-LL-HYLYGDT
(b)
PTPaselB: .AKLPKNKNRNRYRDVSPFDHSRIKL.... H.... QEDNDYINASLIKMEEAQRSYILTQ
rLAR D2: s-N--C--FK--LVNIM-YELT-VC-....QpirgV-GS------FLDGYRQ-KA--A--
rLRP D2: tGN--A-MKK--VLQII-YEFN-VIIpvkrG....E-NT--V---F-DGYRQKD---AS-
PTPaselB: GPLPNTCGHFWEMVWEQKSRGVVMLNRIMEKGSLKCAQYWPQKEEKEMVFDDTNLKLTLI
rLAR D2: ---AESTED--R-L--HN-TII---TKLR-M-RE--H----AERSARYQY.... FVVDPM
rLRP D2: ---LH-TED--R-I--W--CSI---TELE-R-QE-------....SDGLVSYGDITVE-K
PTPaselB: SEDVKSYYTVRQLELENLATQEAREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLS
rLAR D2: A-YNMPQ-IL-EFKVTDARDGQS-T-RQ-QF-D--EQ---KTGEG-ID-IGQ-HKTKEQF
rLRP D2: K-EECES----D-LVT-TRENKS-Q-RQ--FHG--EV-I-SDGKGMI-IIAA-QKQQQQ-
PTPaselB: PEHGPIVVHCSAGIGRSGTFCLADTCLLLHDKRKDPSSVDIKKVLLEMRRFRHGLIQTAD
rLAR D2: GQD---T------V--T-V-ITLSIV-ER-RYEGVVDMFQTV-T-RTQ-PAMVQTEDQYQ
rLRP D2: GN-.--T------A--T----ALS-...VLERV-AEGVL-VFQTVKSL-LQ-PHMV--LE
PTPaselB: QLRFSYLAVIEGAKFIMG
rLAR D2: LCYRAA-EYLGSFDHYAT
rLRP D2: -YE-C-KV-Q-YIDAFSD
Fig 2. Sequence alignment of PTPases
(a) Optimal alignment of the deduced amino acid sequences for the single core PTPase catalytic domain of PTPase lB with the proximal PTPase
domains (Dl) of rat LAR (rLAR) and rat LRP (rLRP). Aligned non-identical amino acids are shown by upper case single-letter code symbols;
unaligned amino acids are shown in lower case; -- -, aligned identical amino acids; ...., a gap introduced for alignment. (b) Alignment of the core
catalytic domain of PTPase LB with the distal PTPase domains (D2) of rat LAR and rat LRP.
(a) (b)
PTPase domain
PTPase 1B
LRP _
34% 33%
LRP 52% 53%
LAR _
39% 30%
LAR
Fig 3. Quantification of the conservation of identical amino acid residues in
the core PTPase domains of rat PTIPase 1B, LRP and LAR derived
from the data presented in Fig. 2
The schematic drawings show either the entire coding region (PTPase
IB) or the cytoplasmic domain (LRP and LAR) with the conserved
PTPase region highlighted (n). (a) Comparison of the PTPase
domains of LRP and LAR with the single domain of PTPase l B. (b)
Comparison between the proximal and distal domains of LRP and
LAR.
skeletal muscle tissue (Zhang & Goldstein, 1991; Goldstein et al.,
1991). To examine the distribution of PTPase lB in normal rat
tissues, the cDNA encoding its full-length sequence was used to
probe a Northern blot containing mRNA from rat brain, kidney,
liver, muscle and spleen (Fig. 1). Expression of PTPase lB
mRNA was found in each tissue as a 4.3 kb transcript, and an
additional mRNA of 1.6 kb was found in liver. These results
confirm the expression of this PTPase homologue in rat liver and
in skeletal muscle, which has not previously been noted. Thus the
three PTPase homologues, LAR, LRP and PTPase 1B, are
expressed in insulin-sensitive tissues and have a potential role in
the regulation of insulin receptor autophosphorylation.
Sequence similarities of the recombinant PTPases
The alignment of the proximal (DI) and distal (D2) core
PTPase domains of rat LAR and LRP with the single PTPase
region of PTPase lB is presented in Fig. 2. Quantification of the
level of conservation of identical amino acids among the PTPase
domains revealed that LAR and LRP have from 30% to 39%
identity with the PTPase lB sequence (Fig. 3). Comparing LRP
with LAR, the proximal and distal PTPase domains had sequence
identities of 52% and 53 % respectively.
Bacterial system for PTPase expression
To initiate studies into the biochemical characteristics of each
of the cloned PTPases, the intact cytoplasmic domains of rat
LAR and LRP, and the full-length coding region of PTPase I B,
were subcloned in the proper reading frame into the inducible
expression vector pKK233-2. For protein expression, the
plasmids were transformed into E. coli strain DHB4, which lacks
1992
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Fig 4. Dephosphorylation of the cognate insulin receptor phosphopeptide
by recombinant PIPases expressed in a bacterial system
Complementary DNAs encoding intact PTPase lB and the cyto-
plasmic domains of LAR and LRP were subcloned into the
expression vector pKK233-2 and transformed into E. coli DHB4
host cells. Cultures were induced with IPTG and cell lysates were
used to assay PTPase activity against the phosphorylated insulin
receptor peptide as described in the Materials and methods section.
The cultures included DHB4 cells carrying the native pKK233-2
vector (---- ), LRP (E), LAR (A) and PTPase lB (0).
endogenous alkaline phosphatase activity. Cultures of logar-
ithmically growing cells were induced with IPTG, sedimented,
and lysates were prepared. Aliquots of equivalent amounts of
bacterial extracts from control cells (transformed with the native
pKK233-2) and those expressing the PTPase cDNAs were
analysed by gel electrophoresis. The appearance of the expected
full-length recombinant protein products, approx. 72 kDa for
LAR and LRP and 50 kDa for PTPase IB, was confirmed for
each strain that was absent in the control cells.
for LAR (P < 0.05 versus PTPase lB by analysis of variance),
1.07 +0.09 mm for LRP and 0.58 +0.13 mM for PTPase lB.
Dephosphorylation of insulin receptors by recombinant PTPases
The activity of the recombinant PTPase domains was further
assessed in vitro towards the dephosphorylation of intact,
autophosphorylated insulin receptors as a potential physiological
substrate from rat liver membranes (Figs. 5 and 6). In these
studies, the dephosphorylation of the 95 kDa insulin receptor ,-
subunit was assessed by gel electrophoresis, autoradiography
and densitometric scanning of the labelled receptor protein after
incubation with each of the bacterial lysates from induced DHB4
cells. With the control extract ofinduced DHB4 cells carrying the
native pKK233-2 vector, minimal dephosphorylation of the
insulin receptors was observed during the incubation period up
to 30 min. Each of the recombinant PTPase preparations was
active in dephosphorylating the autophosphorylated insulin
receptors, although some differences were noted in the initial rate
and the apparent overall extent of receptor dephosphorylation.
Specifically, LAR and PTPase lB displayed similar profiles of
receptor dephosphorylation, whereas LRP had a lower rate of
receptor dephosphorylation over the initial 10 min ofthe reaction
which was also maintained throughout the incubation.
These differences in insulin receptor dephosphorylation could
result either from variations in the amount of active PTPase
expressed from each of the bacterial vector constructs or from
actual variation in the substrate specificity of the individual
enzymes. In order to distinguish between these two possibilities,
we calculated the initial rate of dephosphorylation of the insulin
receptor peptide by each of the PTPases, and compared these
data to the initial rate of intact insulin receptor dephosphoryl-
ation in four replicate experiments similar to those shown in
Figs. 5 and 6. As shown in Table 1, PTPase lB had the highest
relative activity towards the peptide substrate, and this was not
significantly different from that of LAR. LRP, in contrast,
exhibited a 2-3-fold higher relative activity towards the intact
insulin receptor compared with the other recombinant PTPases.
Assay of PTPase activity
The bacterially expressed recombinant PTPases were tested
for their catalytic activity towards insulin-receptor-related
sequences, first using a tyrosyl-phosphorylated peptide substrate
derived from the insulin receptor regulatory domain (Tyr-1 162
region). With the phosphopeptide substrate, the induced DHB4
cells carrying the native pKK233-2 plasmid without a cDNA
insert had no detectable phosphatase activity (Fig. 4). Each of
the bacterial lysates containing the recombinant PTPase domains,
however, was active in dephosphorylating the labelled insulin-
receptor-related peptide. This reaction was essentially linear
throughout the time course of the incubation, and was also
dependent on the amount of enzyme extract present (results not
shown). For the extracts used in these studies, the enzymic
specific activities (pmol of 32P released/min per mg bacterial
extract protein; means+ S.E.M., n = 3) were 32.5 + 4.2, 52.7 + 6.0
and 9.5 + 1.1 for LAR, PTPase lB and LRP respectively.
Inhibitory effects of vanadate and NaF on PTPase activities
Using the peptide substrate assay, each of the expressed
recombinant PTPases was insensitive to NaF, an inhibitor of
serine phosphatases, at concentrations up to 100 mm. Sodium
vanadate, a widely used PTPase inhibitor, blocked the activity of
each of the three PTPases in a dose-dependent fashion. Half-
maximal inhibitory concentrations (IC50) in three replicate
experiments were determined to be 1.50+ 0.12 mM (mean + S.E.M.)
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Fig 5. Dephosphorylation of insulin and EGF receptors by recombinant
PTPases
The intact coding region of PTPase lB and the cytoplasmic domains
of LAR and LRP were expressed by induction of transformed
DHB4 cells as described in the legend to Fig. 4. Aliquots of bacterial
lysate protein (31.5 ,ug) were incubated with autophosphorylated rat
liver insulin receptors (IR) and EGF receptors (EGFR) and after
the indicated period of time the receptors were purified by
immunoprecipitation with anti-phosphotyrosine antibodies and
subjected to gel electrophoresis and autoradiography as described in
the Materials and methods section.
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Fig 6. Quantification of insullin and EGF receptor dephosphorylation by recombinant PTPases
Gel autoradiograms from experiments performed as described in Fig. 5 were quantified by densitometric scanning. The radioactivity remaining
in the 95 kDa insulin receptor fl-subunit (A, A) and the 170 kDa EGF receptor protein (0, 0) was quantified by scanning densitometry of gel
autoradiograms. (a) Control lysate (vector alone; A, 0), and LAR (-, 0); (b) PTPase IB; (c) LRP.
Table 1. Relative initial rates of dephosphorylation of the insulin receptor
peptide and intact insulin receptors by recombinant PTPases
Results are means + S.E.M. (n = 4). * P < 0.05 versus PTPase lB by
analysis of variance with correction applied for three comparisons.
Relative activity
Recombinant PTPase (peptide/intact insulin receptor)
LAR
PTPase lB
LRP
5.33 + 1.03
8.76+ 1.63
2.57 + 0.24*
Table 2. Relative initial rate of simultaneous dephosphorylation of insulin
and EGF receptors by recombinant PTPases
Results are means +S.E.M. of numbers of determinations given in
parentheses. * P < 0.05 versus LAR and PTPase lB by analysis of
variance with correction applied for three comparisons. EGFR,
EGF receptor; IR, insulin receptor.
Relative activity
Recombinant PTPase (peptide/intact insulin receptor)
LAR
PTPase lB
LRP
1.29+0.10
1.28+0.15
1.88 + 0.08*
Simultaneous dephosphorylation of insulin and EGF receptors
by recombinant PTPases
One of the major goals of the present study was to determine
whether the catalytic domains of three PTPases which are
expressed in liver tissue demonstrate a substrate preference
between two autophosphorylated plasma membrane receptors to
which the PTPases might have access in vivo in hepatocytes. To
address this possibility, the relative specificity of the recombinant
PTPase enzymes was assessed in vitro towards the simultaneous
dephosphorylation of intact autophosphorylated insulin and
EGF receptors which were partially purified from rat liver
membranes (Figs. 5 and 6). In these studies the dephosphoryl-
ation of the 95 kDa insulin receptor fl-subunit and the 170 kDa
EGF receptor protein was assessed by gel electrophoresis and
autoradiography ofthe receptor polypeptides as described above.
As noted for the insulin receptor, only minimal dephosphoryl-
ation of the EGF receptor was observed during incubation with
the extract of induced cells carrying only the pKK233-2 vector.
Each of the recombinant PTPase preparations, however, actively
dephosphorylated the labelled EGF receptors with a similar
profile, even though the extracts differed in their total content of
PTPase activity when assayed with the insulin-receptor-related
peptide substrate (seq above).
When the simultaneous dephosphorylations of the two plasma
membrane receptors were compared directly (Fig. 6), a similar
profile of time-dependent insulin and EGF receptor
dephosphorylation was observed with the LAR and PTPase 1B
enzymes. In contrast, the recombinant LRP PTPase produced a
much slower overall dephosphorylation of insulin receptors
compared with EGF receptors present in the same reaction. This
is also demonstrated in the representative experiment shown in
Fig. 5. For a more quantitative assessment of these data,
additional experiments were performed and the initial rate of
dephosphorylation for each receptor was calculated at the earliest
time point, and a ratio of these values was calculated (Table 2).
In accordance with the representative profiles shown in Fig. 5,
these results show that LAR and PTPase lB dephosphorylated
EGF receptors only slightly more rapidly than insulin receptors
(activity ratio 1.3). However, by t test analysis, the EGF/insulin
receptor ratios for LAR and PTPase 1B were not statistically
significantly different from 1.0 (P values of 0.058 and 0.13
respectively), indicating that these enzymes do not markedly
differentiate between the two protein-tyrosine substrates during
the initial stages of the assay. In contrast, the mean initial rate of
EGF receptor dephosphorylation by the recombinant LRP
enzyme was almost twice that for dephosphorylation of the
insulin receptor. This unique substrate preference for the EGF
receptor is substantiated by the significant difference in the
relative activity ratio for LRP compared with the two other
PTPases by analysis of variance after applying a correction for
three comparisons (P < 0.05).
DISCUSSION
PTPases play an essential role in a number of signal
transduction pathways regulated by reversible protein-tyrosine
phosphorylation (Hunter, 1989; Fischer et al., 1991). Previous
work on PTPase enzymes in tissue extracts has demonstrated the
presence of multiple enzymes in both soluble and particulate cell
fractions that have generally been difficult to purify by bio-
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chemical techniques (Rotenberg & Brautigan, 1987: Tonks et al.,
1988c; Roome et al., 1988; Lau et al., 1989; Jones et al., 1989;
Meyerovitch et al., 1989; Gruppuso et al., 1991). These factors
have hindered the isolation and characterization of individual
PTPase homologues from various sources. In the present work
we have taken advantage of the recent molecular cloning of a
number of PTPases to begin to examine the tissue expression and
catalytic properties of individual PTPase enzymes in vitro. These
studies will enable us to gain some insight into whether these
enzymes have generalized or more specific physiological roles in
intact cells, with particular attention to the regulation of sig-
nalling by tyrosine kinase receptors in normal tissues.
First, we have identified several cloned PTPase enzymes which
are expressed in tissues such as liver and skeletal muscle, where
one of the critical roles of PTPases is in the regulation of insulin
action and metabolic homeostasis in vivo. Our previous work
and the data reported herein show that LAR, LRP and PTPase
lB are major PTPase homologues in these insulin-sensitive tissues
and may thus play a role in the regulation of signalling by the
insulin receptor. Although similar in their conservation of specific
residues found in core PTPase sequences (Krueger et al., 1990),
the catalytic domains of these enzymes retained a substantial
degree of structural divergence that might be expected to produce
differences in their catalytic activity towards potentially relevant
substrates for the enzymes in vivo, and suggest a mechanistic role
for the enzymes in intact cells. In order to examine this possibility,
we assayed the relative activities of their catalytic domains
towards a phosphopeptide substrate and two autophosphorylated
plasma membrane receptors that are also found in liver cells.
Interestingly, the relative activities of LAR and PTPase lB
with the phosphopeptide and the intact autophosphorylated
insulin receptor were not significantly different (Table 1). In
addition, the rate of simultaneous dephosphorylation of insulin
and EGF receptors was not significantly different between LAR
and PTPase lB. Thus these two enzymes have similar catalytic
activities towards a variety of protein-tyrosine substrates and
recognize autophosphorylation sites, e.g. on both insulin and
EGF receptors, which contain multiple phosphorylated protein-
tyrosine moieties. These findings were somewhat unexpected,
since these recombinant enzymes have significantly different
overall structures, with LAR having two tandem PTPase domains
and PTPase lB only a single domain (Fig. 3). It is of interest that
most of the catalytic activity of LCA (CD45) and LAR is
contained in the proximal PTPase domain in studies using site-
directed mutagenesis and bacterial expression of truncated
recombinant cDNA constructs (Streuli et al., 1990; Pot et al.,
1991). Thus, although LAR has tandemly conserved PTPase
domains, it appears that the active proximal domain alone
exhibits a similar catalytic activity to PTPase lB. While the
second domain of LAR may not be catalytically active, it is
highly conserved between species, suggesting that it may possibly
play an important role in regulation of the PTPase domain by its
interaction with potential substrates or associated proteins in
vivo.
The recombinant cytoplasmic domain of LRP exhibited mark-
edly different properties when compared with the activities of
LAR and PTPase IB, including a significantly higher preference
for the dephosphorylation of both the intact insulin receptor and
EGF receptor protein compared with the receptor peptide
substrate. These results suggest that, for the recombinant LRP
enzyme, assays using the insulin receptor peptide, or perhaps
other peptide substrates, may not reflect its potential activity
with other larger proteins or specific substrates with possible
physiological relevance. In addition, LRP produced a much
slower overall dephosphorylation of insulin receptors compared
with EGF receptors in a simultaneous reaction, raising the
possibility that, in intact cells, the EGF receptor may be a
preferential substrate for LRP.
A number of biochemical properties of purified placental
PTPase lB (Tonks et al., 1988b) or recombinant forms of LAR
and LRP (Krueger et al., 1990; Cho et al., 1991; Daum et al.,
1991; Streuli et al., 1990; Pot et al., 1991) have been examined in
separate studies using several peptide and protein substrates. In
general, while maintaining specificity for protein-tyrosine
moieties, these PTPases have many properties in common,
including the ability to dephosphorylate a variety of substrates
with only relative preferences and sensitivities to certain inhibitors
and activating agents. The results of our present work are in
agreement with previous data that the human homologue of
PTPase lB (Tonks et al., 1988b) will dephosphorylate insulin
receptors, and that recombinant human LAR (Goldstein et al.,
1991) is active against both insulin and EGF receptors. How-
ever, the present work represents the first assessment of receptor
dephosphorylation by LRP and, furthermore, our studies allow
for a direct comparison of relative PTPase activities towards the
two autophosphorylated receptor substrates.
The potential role of PTPase 1B, LAR and LRP in the
physiological dephosphorylation of insulin receptors is also
further supported by their presumed subcellular localization,
since the bulk of insulin receptor dephosphorylating activity is
found in the particulate fraction of liver and hepatoma cells
(Sale, 1991; Goldstein et al., 1991). LAR and LRP are
transmembrane enzymes, and recent work has shown that PTPase
1B, while structurally lacking a transmembrane domain, is also
associated with a particulate fraction of cells by virtue of its
interaction with a non-catalytic subunit protein or through
hydrophobic interactions (Cool et al., 1990; Woodford et al.,
1991; Pallen et al., 1991; Brautigan & Pinault, 1991).
An additional factor which remains to be studied is whether
these PTPases differ not only in their overall dephosphorylation
of the insulin receptor, but also in their action on specific
phosphotyrosine sites in the insulin receptor regulatory domain
that are critical to the regulation of the intrinsic kinase activity
of the receptor. Insulin-stimulated autophosphorylation of its
receptor occurs as a sequential cascade involving both the
receptor kinase domain and the C-terminus (Tornqvist et al.,
1987; White et al., 1988; Tavare & Denton, 1988; Flores-Riveros
et al., 1989). Recent work has shown that autophosphorylation
of three tyrosine residues in the so-called receptor 'regulatory
domain' is required for activation of the insulin receptor kinase
towards exogenous substrates (White et al., 1988; Flores-Riveros
et al., 1989). Other related studies have shown that the triply-
phosphorylated form of the regulatory region of isolated insulin
receptors was rapidly dephosphorylated by the PTPase activity
present in extracts of rat liver, and that the initial dephosphoryl-
ation of this region was also closely correlated with deactivation
of the receptor kinase activity (King & Sale, 1990; King et al.,
1991). Thus the action of one or more cellular PTPases might be
to limit progression of specific events in the receptor
autophosphorylation cascade and attenuate the activation of the
receptor kinase.
In conclusion, these studies have demonstrated a number of
similarities and differences in the catalytic activities of three
major hepatic PTPases towards plasma membrane receptors that
are also expressed in liver. While each PTPase had activity
towards both autophosphorylated receptors, LRP exhibited a
significantly accelerated initial dephosphorylation of the EGF
receptor over the insulin receptor protein. Overall, these data
provide evidence that each of these PTPases may act
physiologically to dephosphorylate insulin and EGF receptors.
Our results further suggest that, rather than having specificity for
certain cellular substrates, PTPases may serve a more generalized
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function in intact cells and act on a number of phosphotyrosine-
containing substrates. Redundant PTPase activities may exist in
cells to provide a buffer of control over the steady-state level of
critical protein-tyrosine phosphorylations and keep metabolic
and other cellular signalling pathways in balance. An alternative
hypothesis is that the cellular action of the intact forms of these
and other PTPases in vivo is potentially modulated by a number
of factors, including steric considerations, compartmentalization
within the cell, and potential interactions with other regulatory
proteins that may strongly influence substrate specificity and
catalytic activity. Further studies involving expression of these
PTPases in insulin-sensitive cultured cells will begin to answer
some of these questions.
Note added in proof (received 16 March 1992)
The dephosphorylation of both insulin and EGF receptors by
PTPase IB has also been recently reported by Tappia et al.
(1991).
We thank Dr. Haruo Saito for providing us with a segment of the
human LAR cDNA and a culture of DHB4 cells. Anti-phosphotyrosine
antibodies were kindly provided by Dr. Montse Miralpeix and Dr.
Morris White. We are also grateful to Eric Britton for his contribution
to this work during a 1991 Juvenile Diabetes Foundation Summer
Student Fellowship, Alana Dudley for technical assistance and Dr. C.
Ronald Kahn for his support and helpful discussion. This project was
supported by a Research and Development Award from the American
Diabetes Association and NIH grant DK43396, both to B. J. G.
Molecular Core laboratory services were provided by the Joslin
Diabetes and Endocrinology Research Center Grant DK36836.
REFERENCES
Amann, E. & Brosius, J. (1985) Gene 40, 183-190
Aviv, H. & Leder, P. (1972) Proc. Natl. Acad. Sci. USA 69, 1408-1412
Boyd, D., Manoil, C. & Beckwith, J. (1987) Proc. Natl. Acad. Sci. USA
84, 8525-8529
Brautigan, D. L. & Pinault, F. M. (1991) Proc. Natl. Acad. Sci. USA 88,
6696-6700
Chernoff, J., Schievella, A. R., Jost, C. A., Erikson, R. L. & Neel, B. G.
(1990) Proc. Natl. Acad. Sci. USA 87, 2735-2739
Cho, H. J., Ramer, S. E., Itoh, M., Winkler, D. G., Kitas, E., Bannwarth,
W., Burn, P., Saito, H. & Walsh, C. T. (1991) Biochemistry 30,
6210-6216
Chomczynski, P. & Sacchi, N. (1987) Anal. Biochem. 162, 156-159
Cicirelli, M. F., Tonks, N. K., Diltz, C. D., Weiel, J. E., Fischer, E. H. &
Krebs, E. G. (1990) Proc. Natl. Acad. Sci. USA 87, 5514-5518
Cool, D. E., Tonks, N. K., Charbonneau, H., Walsh, K. A., Fischer,
E. H. & Krebs, E. G. (1989) Proc. Natl. Acad. Sci. U.S.A. 86,
5257-5261
Cool, D. E., Tonks, N. K., Charbonneau, H., Fischer, E. H. & Krebs,
E. G. (1990) Proc. Natl. Acad. Sci. U.S.A. 87, 7280-7284
Daum, G., Zander, N. F., Morse, B., Hurwitz, D., Schlessinger, J. &
Fischer, E. H. (1991) J. Biol. Chem. 266, 12211-12215
Davis, L. G., Dibner, M. D. & Battey, J. F. (1986) Basic Methods in
Molecular Biology, Elsevier, New York
Ebina, Y., Ellis, L., Jarnagin, K., Edery, M., Graf, L., Clauser, E., Ou,
J.-h., Masiarz, F., Kan, Y. W., Goldfine, I. D., Roth, R. A. & Rutter,
W. J. (1985) Cell 40, 747-758
Feinberg, A. P. & Vogelstein, B. (1983) Anal. Biochem. 132, 6-13
Fischer, E. H., Charbonneau, H. & Tonks, N. K. (1991) Science 253,
401-406
Flores-Riveros, J. R., Sibley, E., Kastelic, T. & Lane, M. D. (1989)
J. Biol. Chem. 264, 21557-21572
Goldstein, B. J. (1992) J. Cell. Biochem. 48, 33-42
Goldstein, B. J. & Dudley, A. L. (1990) Mol. Endocrinol. 4, 235-244
Goldstein, B. J., Meyerovitch, J., Zhang, W. R., Backer, J. M., Csermely,
P., Hashimoto, N. & Kahn, C. R. (1991a) Adv. Protein Phosphatases
6, 1-17
Received 4 November 1991; accepted 7 January 1992
Goldstein, B. J., Zhang, W. R., Hashimoto, N. & Kahn, C. R. (1992)
Mol. Cell. Biochem. 109, 107-113
Gruppuso, P. A., Boylan, J. M., Smiley, B. L., Fallon, R. J. & Brautigan,
D. L. (1991) Biochem. J. 274, 361-367
Guan, K. L., Haun, R. S., Watson, S. J., Geahlen, R. L. & Dixon, J. E.
(1990) Proc. Natl. Acad. Sci. USA 87, 1501-1505
Hunter, T. (1989) Cell 58, 1013-1016
Jirik, F. R., Janzen, N. M., Melhado, I. G. & Harder, K. W. (1990)
FEBS Lett. 273, 239-242
Jones, S. W., Erikson, R. L., Ingebritsen, V. M. & Ingebritsen, T. S.
(1989) J. Biol. Chem. 264, 7747-7753
Kaplan, R., Morse, B., Huebner, K., Croce, C., Howk, R., Ravera, M.,
Ricca, G., Jaye, M. & Schlessinger, J. (1990) Proc. Natl. Acad. Sci.
USA 87, 7000-7004
Kasuga, M., White, M. F. & Kahn, C. R. (1985) Methods Enzymol. 109,
609-621
King, M. J. & Sale, G. J. (1990) Biochem. J. 266, 251-259
King, M. J., Sharma, R. P. & Sale, G. J. (1991) Biochem J. 275, 413-418
Krueger, N. X., Streuli, M. & Saito, H. (1990) EMBO J. 9, 3241-3252
Laenmili, U. K. (1970) Nature (London) 277, 680-685
Lau, K. H., Farley, J. R. & Baylink, D. J. (1989) Biochem. J. 257, 23-
36
Matthews, R. J., Cahir, E. D. & Thomas, M. L. (1990) Proc. Natl. Acad.
Sci. USA 87, 4444 4448
McGuire, M. C., Fields, R. M., Nyomba, B. L., Raz, I., Bogardus, C.,
Tonks, N. K. & Sommercorn, J. (1991) Diabetes 40, 939-942
Meyerovitch, J., Backer, J. M. & Kahn, C. R. (1989) J. Clin. Invest. 84,
976-983
Pallen, C. J., Lai, D. S., Chia, H. P., Boulet, I. & Tong, P. H. (1991)
Biochem. J. 276, 315-323
Pot, D. A., Woodford, T. A., Remboutsika, E., Haun, R. S. & Dixon,
J. E. (1991) J. Biol. Chem. 266, 19688-19696
Roome, J., O'Hare, T., Pilch, P. F. & Brautigan, D. L. (1988) Biochem.
J. 256, 493-500
Rotenberg, S. A. & Brautigan, D. L. (1987) (Biochem. J. 243, 747-754
Sale, G. J. (1991) Adv. Protein Phosphatases 6, 159-186
Sambrook, J., Fritsch, E. F. & Maniatis, T. (1989) Molecular Cloning:
A Laboratory Manual, 2nd edn., Cold Spring Harbor Laboratory
Press, Cold Spring Harbor
Sanger, F., Nicklen, S. & Coulson, A. R. (1977) Proc. Natl. Acad. Sci.
USA 74, 5463-5467
Sap, J., DEustachio, P., Givol, D. & Schlessinger, J. (1990) Proc. Natl.
Acad. Sci. USA 87, 6112-6116
Schacter, E. (1984) Anal. Biochem. 138, 416-420
Sparks, J. W. & Brautigan, D. L. (1985) J. Biol. Chem. 260, 2042-2045
Streuli, M., Krueger, N. X., Hall, L. R., Schlossman, S. F. & Saito, H.
(1988) J. Exp. Med. 168, 1523-1530
Streuli, M., Krueger, N. X., Tsai, A. Y. & Saito, H. (1989) Proc. Natl.
Acad. Sci. USA 86, 8698-8702
Streuli, M. Krueger, N. X., Thai, T., Tang, M. & Saito, H. (1990) EMBO
J. 9, 2399-2407
Tappia, P. S., Sharma, R. P. & Sale, G. J. (1991) Biochem. J. 278, 69-
74
Tavare, J. M. & Denton, R. M. (1988) Biochem. J. 252, 607-615
Thomas, M. L. (1989) Annu. Rev. Immunol. 7, 339-369
Tonks, N. K., Charbonneau, H., Diltz, C. D., Fischer, E. H. & Walsh'
K. A. (1988a) Biochemistry 27, 8695-8701
Tonks, N. K., Diltz, C. D. & Fischer, E. H. (1988b) J. Biol. Chem. 263,
6731-6737
Tonks, N. K., Diltz, C. D. & Fischer, E. H. (1988c) J. Biol. Chem. 263,
6722-6730
Tonks, N. K., Cicirelli, M. F., Diltz, C. D., Krebs, E. G. & Fischer,
E. H. (1990) Mol. Cell. Biol. 10, 458-463
Tornqvist, H. E., Pierce, M. W., Frackelton, A. R., Nemenoff, R. A. &
Avruch, J. (1987) J. Biol. Chem. 262, 10212-10219
White, M. F., Stegmann, E. W., Dull, T. J., Ullrich, A. & Kahn, C. R.
(1987) J. Biol. Chem. 262, 9769-9777
White, M. F., Shoelson, S. E., Keutmann, H. & Kahn, C. R. (1988)
J. Biol. Chem. 263, 2969-2980
Woodford, T. A., Guan, K. L. & Dixon, J. E. (1991) Adv. Protein
Phosphatases. 6, 503-524
Yarden, Y. & Ullrich, A. (1988) Annu. Rev. Biochem. 57, 443-478
Zhang, W. R. & Goldstein, B. J. (1991) Biochem. Biophys. Res.
Commun. 178, 1291-1297
1992
576
